Speciality Medicines H1 FY27 Results: PAT Surges 83% YoY to ₹8.88 Crore
Speciality Medicines Ltd · Financial Result · 12 Nov 2026, 10:00 pm
Speciality Medicines H1 FY27 Results: PAT Surges 83% YoY to ₹8.88 Crore Speciality Medicines reported revenue from operations of ₹86.95 crore for the half-year ended 30th Sep'26, jumping 185% YoY from ₹30.50 crore and 94% QoQ from ₹44.78 crore in the preceding half-year. Net profit rose 83.18% YoY and 8.58% QoQ to ₹8.88 crore, compared to ₹4.85 crore in H1 FY26. Diluted EPS stood at ₹10.11 versus ₹7.54 YoY. Additionally, the company reported zero deviation in utilizing its ₹29.14 crore IPO proceeds, having deployed ₹17.95 crore by 30th Sep'26.
Original exchange filing (PDF)
More announcements from Speciality Medicines Ltd
- We hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on November 12, 2026, at the Corporate Office of the Company which was commenced .... · 12 Nov 2026
- Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve 1. Unaudited Standalone .... · 12 Nov 2026
- We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company. · 28 Sept 2026
- We hereby submit Proceedings of 5th AGM of the Company. · 28 Sept 2026
- We hereby Submit Annual Report of FY 2025-26. · 04 Sept 2026
- We hereby submit Notice of 5th AGM to be held on September 28, 2026. · 04 Sept 2026
- We hereby submit Outcome of the board meeting held on September 03, 2026 · 03 Sept 2026
- We hereby submit intimation regarding approval for Two new products in Ethiopia. · 12 Aug 2026
